Cytosorbents (CTSO) Operating Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -743.00 |
| Dec 31, 2025 | -2,545.00 |
| Sep 30, 2025 | -1,159.00 |
| Jun 30, 2025 | -392.00 |
| Mar 31, 2025 | -1,608.00 |
| Dec 31, 2024 | 3,600.00 |
| Sep 30, 2024 | 3,625.00 |
| Jun 30, 2024 | 1,787.00 |
| Mar 31, 2024 | 3,074.00 |
| Dec 31, 2023 | -1,669.00 |
| Sep 30, 2023 | -3,622.00 |
| Jun 30, 2023 | 314.00 |
| Mar 31, 2023 | -2,054.00 |
| Dec 31, 2022 | 1,420.00 |
| Sep 30, 2022 | -5,497.00 |
| Jun 30, 2022 | -3,301.00 |
| Mar 31, 2022 | -3,962.00 |
| Dec 31, 2021 | 5,954.00 |
| Sep 30, 2021 | 3,352.00 |
| Jun 30, 2021 | 7,997.00 |
| Mar 31, 2021 | 8,855.00 |
| Dec 31, 2020 | 10,371.00 |
| Sep 30, 2020 | 14,146.00 |
| Jun 30, 2020 | 19,741.00 |
| Mar 31, 2020 | 34,655.00 |
| Dec 31, 2019 | 25,789.00 |
| Sep 30, 2019 | 3,530.00 |
| Jun 30, 2019 | 7,482.00 |
| Mar 31, 2019 | 2,612.00 |
| Dec 31, 2018 | -3,941.00 |
| Sep 30, 2018 | 8,274.00 |
| Jun 30, 2018 | 102,660.00 |
| Mar 31, 2018 | 74,466.00 |
| Dec 31, 2017 | 84,231.00 |
| Sep 30, 2017 | 433,871.00 |
| Jun 30, 2017 | 195,365.00 |
| Mar 31, 2017 | 207,482.00 |
| Dec 31, 2016 | 253,606.00 |